Een spelwijziging in continue biosensing: moleculair ontworpen, op affiniteit gebaseerde nanoschakelaars voor persoonlijke monitoring KU Leuven
Generic technology that allows continuous sensing of a wide range of biomolecular parameters could revolutionise patient monitoring and enable truly personalised therapy. Commercial sensors are available for continuous monitoring of glucose, but do not exist for other molecules that are important for monitoring disease status and treatment effect, including peptides, proteins, hormones, and drugs. The ambition of CONSENSE is to provide a game ...